ID   UK1-3
SY   UK 1-3
DR   CCRID; 4201PAT-CCTCC00057
DR   JCRB; IFO50176
DR   Wikidata; Q98133940
RX   Patent=US5496549;
RX   Patent=US5506135;
RX   PubMed=1796414;
RX   PubMed=2107601;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2083.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Discontinued: JCRB; IFO50176; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
RX   Patent=US5496549;
RA   Yamazaki H., Tanoue K., Iwasa S., Kurokawa T.;
RT   "Bispecific monoclonal antibodies, thrombolytic agent
RT   and method of cell lysis.";
RL   Patent number US5496549, 05-Mar-1996.
RX   Patent=US5506135;
RA   Iwasa S., Kurokawa T., Toyoda Y.;
RT   "Hybrid monoclonal antibodies, their production and use.";
RL   Patent number US5506135, 09-Apr-1996.
RX   PubMed=1796414; DOI=10.1055/s-0038-1646486;
RA   Kurokawa T., Iwasa S., Kakinuma A., Stassen J.-M., Lijnen H.R.,
RA   Collen D.;
RT   "Enhancement of clot lysis in vitro and in vivo with a bispecific
RT   monoclonal antibody directed against human fibrin and against
RT   urokinase-type plasminogen activator.";
RL   Thromb. Haemost. 66:684-693(1991).
RX   PubMed=2107601; DOI=10.1016/0049-3848(90)90382-M;
RA   Kurokawa T., Iwasa S., Kakinuma A.;
RT   "Enhancement of fibrinolysis by bispecific monoclonal antibodies
RT   reactive to fibrin and plasminogen activators.";
RL   Thromb. Res. 47 Suppl. 10:83-89(1990).